---
document_datetime: 2023-09-21 20:58:41
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/ponvory-epar-all-authorised-presentations_en.pdf
document_name: ponvory-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.4159999
conversion_datetime: 2025-12-22 20:26:20.240404
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## MA (EU) number (Invented) name Strength Pharmaceutical Form Route of Administration Immediate Packaging Pack size

EU/1/21/1550/001 PONVORY 2 mg+3 mg+4 mg+5 mg+6 mg+7 mg+8 mg+9 mg+ 10 mg Film-coated tablet Oral use blister (OPA/alu/PE+DES/PET /alu/PE) Initiation pack 14 tablets (2 x 2 mg + 2 x 3 mg + 2 x 4 mg + 1 x 5 mg + 1 x 6 mg + 1 x 7 mg + 1 x 8 mg + 1 x 9 mg + 3 x 10 mg) EU/1/21/1550/002 PONVORY 20 mg Film-coated tablet Oral use blister (OPA/alu/PE+DES/PET /alu/PE) 28 tablets EU/1/21/1550/003 PONVORY 20 mg Film-coated tablet Oral use blister (OPA/alu/PE+DES/PET /alu/PE) 84 (3x28) tablets (multipack)